Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
- PMID: 16169905
- PMCID: PMC1236580
- DOI: 10.1073/pnas.0506735102
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Abstract
Although the finding of severe acute respiratory syndrome coronavirus (SARS-CoV) in caged palm civets from live animal markets in China has provided evidence for interspecies transmission in the genesis of the SARS epidemic, subsequent studies suggested that the civet may have served only as an amplification host for SARS-CoV. In a surveillance study for CoV in noncaged animals from the wild areas of the Hong Kong Special Administration Region, we identified a CoV closely related to SARS-CoV (bat-SARS-CoV) from 23 (39%) of 59 anal swabs of wild Chinese horseshoe bats (Rhinolophus sinicus) by using RT-PCR. Sequencing and analysis of three bat-SARS-CoV genomes from samples collected at different dates showed that bat-SARS-CoV is closely related to SARS-CoV from humans and civets. Phylogenetic analysis showed that bat-SARS-CoV formed a distinct cluster with SARS-CoV as group 2b CoV, distantly related to known group 2 CoV. Most differences between the bat-SARS-CoV and SARS-CoV genomes were observed in the spike genes, ORF 3 and ORF 8, which are the regions where most variations also were observed between human and civet SARS-CoV genomes. In addition, the presence of a 29-bp insertion in ORF 8 of bat-SARS-CoV genome, not in most human SARS-CoV genomes, suggests that it has a common ancestor with civet SARS-CoV. Antibody against recombinant bat-SARS-CoV nucleocapsid protein was detected in 84% of Chinese horseshoe bats by using an enzyme immunoassay. Neutralizing antibody to human SARS-CoV also was detected in bats with lower viral loads. Precautions should be exercised in the handling of these animals.
Figures
Similar articles
-
Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.J Virol. 2015 Oct;89(20):10532-47. doi: 10.1128/JVI.01048-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269185 Free PMC article.
-
Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses.Hong Kong Med J. 2012 Feb;18 Suppl 2:25-6. Hong Kong Med J. 2012. PMID: 22311357
-
Molecular epidemiology, evolution and phylogeny of SARS coronavirus.Infect Genet Evol. 2019 Jul;71:21-30. doi: 10.1016/j.meegid.2019.03.001. Epub 2019 Mar 4. Infect Genet Evol. 2019. PMID: 30844511 Free PMC article. Review.
-
Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events.J Virol. 2010 Mar;84(6):2808-19. doi: 10.1128/JVI.02219-09. Epub 2010 Jan 13. J Virol. 2010. PMID: 20071579 Free PMC article.
-
A review of studies on animal reservoirs of the SARS coronavirus.Virus Res. 2008 Apr;133(1):74-87. doi: 10.1016/j.virusres.2007.03.012. Epub 2007 Apr 23. Virus Res. 2008. PMID: 17451830 Free PMC article. Review.
Cited by
-
Unveiling bat-borne viruses: a comprehensive classification and analysis of virome evolution.Microbiome. 2024 Nov 14;12(1):235. doi: 10.1186/s40168-024-01955-1. Microbiome. 2024. PMID: 39543683 Free PMC article.
-
Broad cross neutralizing antibodies against sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans.NPJ Vaccines. 2024 Oct 22;9(1):195. doi: 10.1038/s41541-024-00997-8. NPJ Vaccines. 2024. PMID: 39438493 Free PMC article.
-
Study on sentinel hosts for surveillance of future COVID-19-like outbreaks.Sci Rep. 2024 Oct 19;14(1):24595. doi: 10.1038/s41598-024-76506-7. Sci Rep. 2024. PMID: 39427096 Free PMC article.
-
Assay Development and Validation for Innovative Antiviral Development Targeting the N-Terminal Autoprocessing of SARS-CoV-2 Main Protease Precursors.Viruses. 2024 Jul 29;16(8):1218. doi: 10.3390/v16081218. Viruses. 2024. PMID: 39205192 Free PMC article.
-
Climate Changes and COVID-19.Adv Exp Med Biol. 2024;1458:217-231. doi: 10.1007/978-3-031-61943-4_14. Adv Exp Med Biol. 2024. PMID: 39102199 Review.
References
-
- Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., et al. (2003) N. Engl. J. Med. 348, 1967-1976. - PubMed
-
- Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) N. Engl. J. Med. 348, 1953-1966. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
